https://www.selleckchem.com/pr....oducts/muvalaplin.ht
There is a paucity of data regarding the aetiology of atrioventricular heart block (AV in young and middle-aged patients, particularly from low- and middle-income countries. To determine the aetiology of AVB in patients ≤ 55 years treated with transvenous pacemakers in a low- or middle-income country. We performed a retrospective review of all patients who received a transvenous pacemaker for newly diagnosed AVB from 01/01/2013 to 31/12/2020 at Groote Schuur Hospital, Cape Town, South Africa. One thousand one hundred one (1101) con